101
|
Kim J, Kim H, Hong M, Bang I, Kim R, Jung H, Cho H, Kim H, Kim H, Cho B. P3.01-028 Efficacy of Osimertinib for Brain Metastasis in Advanced NSCLC: Data from Single Center in ASTRIS Trial. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
102
|
Hong M, Ahn B, Kim H, Heo S, Kim J, Bang I, Kim R, Jung H, Cho H, Kim H, Kim H, Cho B. MA 11.09 Real World Data of Rebiopsy, Mutation Status, and Its Association with Plasma Genotyping after EGFR TKI Failure in NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
103
|
Jin W, Mellon E, Frakes J, Murimwa G, Hodul P, Pimiento J, Soares H, Kim R, Malafa M, Hoffe S. Can Total Psoas Area Predict Toxicity After Stereotactic Body Radiation Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancers? Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
104
|
Frakes J, Naghavi A, Ahmed K, Strom T, Harrison L, Giuliano A, Mule J, Berglund A, Anaya D, Kim R, Eschrich S, Torres-Roca J, Hoffe S. Hepatocellular Carcinoma and Association With Tumor Radiosensitivity and Immune Activation. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
105
|
Kim R, Jeon B, Kim H. Video-based analysis of the long-term effect of subthalamic nucleus deep brain stimulation on freezing of gait in Parkinson disease: A retrospective study. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
106
|
Choi K, Park E, Cho Y, Choi H, Choe S, Kim R, Yoon T, Kang I, Koong M, Kim Y, Sim C, Park D, Lee J, Kim J. Efficiancy of all frozen embryo transfer in IVF cycles with late developing blastocyst: improve the asynchrony between the embryo and endometrium. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.1085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
107
|
Kim R, Sarker D, Macarulla T, Yau T, Choo S, Meyer T, Hollebecque A, Whisenant J, Sung M, Yoon JH, Lim H, Zhu A, Park JW, Faivre S, Mazzaferro V, Shi H, Schmidt-Kittler O, Clifford C, Wolf B, Kang YK. Phase 1 safety and clinical activity of BLU-554 in advanced hepatocellular carcinoma (HCC). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx367] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
108
|
White B, Romano S, Judd R, Kim R, Kim H, Klem I, Heiner J, Shah D, Jue J, Indorkar R, Farzaneh-Far A. 5008Global longitudinal strain measured using feature-tracking cardiac magnetic resonance imaging is an independent predictor of death in patients with reduced ejection fraction: a multicenter study. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.5008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
109
|
Olcina M, Kim R, Giaccia A. SP-0078: Best of both worlds: can novel pathways be targeted for reduced gut toxicity but improved tumour response? Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30522-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
110
|
Seo HH, Lee SY, Lee CY, Kim R, Kim P, Oh S, Lee H, Lee MY, Kim J, Kim LK, Hwang KC, Chang W. Exogenous miRNA-146a Enhances the Therapeutic Efficacy of Human Mesenchymal Stem Cells by Increasing Vascular Endothelial Growth Factor Secretion in the Ischemia/Reperfusion-Injured Heart. J Vasc Res 2017; 54:100-108. [DOI: 10.1159/000461596] [Citation(s) in RCA: 43] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2016] [Accepted: 02/08/2017] [Indexed: 11/19/2022] Open
|
111
|
Kim R, Kawai A, Wakisaka M, Funaoka Y, Yasuda N, Ohtani S, Ito M, Arihiro K. A role for immune response in the response to neoadjuvant chemotherapy for breast cancer patients. Breast 2017. [DOI: 10.1016/s0960-9776(17)30260-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
112
|
Kim R, Peterson A, Isherwood A, Uppal H, Barlev A. Abstract P5-08-28: Incidence of germline BRCA1- and BRCA2-mutated breast cancer in the US. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-08-28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Breast cancer is the most common cancer and second leading cause of cancer death among women in the United States (US).1 Inherited mutations in germline breast cancer susceptibility gene 1 and 2 (gBRCAm) are associated with increased risk of developing cancers, including breast cancer.2 No published reports of gBRCAm incidence within an unselected US breast cancer population are available based on a comprehensive literature review (CLR). The main objective of this analysis is to estimate the incidence of gBRCAm breast cancer in the US.
Methods: For this analysis the Surveillance, Epidemiology, and End Results (SEER) Program 18 registries captured incidence of breast cancer by stage, age and gender.3 The size of the US population was based on United Nation's population projections and standardized to the 2010 population.4 Age-specific gBRCAm distribution and gBRCAm-specific hormonal subtype for estrogen-receptor and progesterone-receptor (ER/PR), and human epidermal growth factor receptor-2 (HER2) estimates were determined from a CLR.5-8 Tumor cells negative for ER/PR and HER2 are referred to as triple-negative breast cancer (TNBC).
Results: In 2016, it is projected that approximately 250,000 individuals will be diagnosed with invasive breast cancer (all genders). Median age range of the population with invasive breast cancer is 65-69 years and 99% are females. Majority (72%) of female invasive breast cancer cases are ER/PR+ whereas 11% of cases are TNBC. Corroborating with current publications, gBRCAm is estimated at 5% for individuals less than 50 years old and 1% among all ages. Median age range of the gBRCAm cohort is 40-44 years. After applying currently available gBRCAm specific literature parameters, the majority (55%) of gBRCAm diagnoses are TNBC.
Conclusion: In the US, patients with gBRCAm represent a small proportion (1%) of all breast cancer tissues evaluated. Majority of gBRCAm patients are diagnosed with TNBC (55%) and are younger (median age range 40-44 years) than overall breast cancer population. Age differences noticed in gBRCAm may have been due to disparity in genetic screening practices among breast cancer population in the US rather than a reflection of gBRCAm expressions. These estimates of gBRCAm incidence are driven by limited reports on an unselected population of breast cancer gBRCAm cohort; therefore sensitivity analysis is required to assess the robustness of these estimates.
1. American Cancer Society. Facts and Figures 2016.
2. Miki Y et al. Science. 1994;266:66-71.
3. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2013), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission.
4. United Nations Population Division. World Population Prospects, the 2015 Revision. http://esa.un.org/unpd/wpp/.
5. van den Broek et al. Eur J Hum Genet. 2015;23:588-95.
6.Turkovic L et al. BMC Cancer. 2010;10:466.
7. Atchley DP et al. J Clin Oncol. 2008;26:4282-4321.
8. Spurdle AB et al. Breast Cancer Res. 2014;16:3419.
Citation Format: Kim R, Peterson A, Isherwood A, Uppal H, Barlev A. Incidence of germline BRCA1- and BRCA2-mutated breast cancer in the US [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-08-28.
Collapse
|
113
|
Yoon SH, Kim R, Lee CS. Analysis of Death Certificate Errors of a University Hospital Emergency Room. ACTA ACUST UNITED AC 2017. [DOI: 10.7580/kjlm.2017.41.3.61] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
114
|
Kim R, Park SI, Lee CY, Lee J, Kim P, Oh S, Lee H, Lee MY, Kim J, Chung YA, Hwang KC, Maeng LS, Chang W. Alternative new mesenchymal stem cell source exerts tumor tropism through ALCAM and N-cadherin via regulation of microRNA-192 and -218. Mol Cell Biochem 2016; 427:177-185. [PMID: 28039611 PMCID: PMC5306073 DOI: 10.1007/s11010-016-2909-5] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2016] [Accepted: 12/03/2016] [Indexed: 12/26/2022]
Abstract
Gliomas are the most common type of malignant primary brain tumors. Some treatments of gliomas exist, but they are rarely curative. Mesenchymal stem cells (MSCs) are emerging as potential modes of targeted cancer therapy owing to their capacity for homing toward tumor sites. It has been proposed that MSCs derived from various sources, such as bone marrow, adipose tissue and umbilical cord blood, can be used as cell-based therapy for brain tumors. Here, MSCs obtained from the synovial fluid of osteoarthritis or rheumatoid arthritis patients were investigated as therapeutic candidates. Specifically, we compared migratory and adhesive abilities, as well as expression levels of related genes and microRNA in bone marrow derived-MSCs (BMMSCs), adipose derived-MSCs (ADMSCs), and synovial fluid derived-MSCs (SFMSCs) after treatment with conditioned medium from gliomas. Migration and adhesion of SFMSCs increased through upregulation of the activated lymphocyte cell adhesion molecule (ALCAM) and N-cadherin by microRNA-192 and -218 downregulation, similar to BMMSCs and ADMSCs. Migratory capacities of all types of MSCs were evaluated in vivo, and SFMSCs migrated intensively toward gliomas. These results suggest that SFMSCs have potential for use in cell-based antitumor therapies.
Collapse
|
115
|
Kim R, Sharma S, Meyer T, Sarker D, Macarulla T, Sung M, Choo S, Shi H, Schmidt-Kittler O, Clifford C, Wolf B, Llovet J. First-in-human study of BLU-554, a potent, highly-selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)32704-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
116
|
Pearson A, Jin W, Mellon E, Frakes J, Strom T, Springett G, Kim R, Mahipal A, Hodul P, Pimiento J, Shridhar R, Malafa M, Hoffe S. Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
117
|
Mohammadi H, Abuodeh Y, Jin W, Frakes J, Friedman M, Biebel B, Choi J, El-Haddad G, Kis B, Sweeney J, Kim R, Pimiento J, Malafa M, Anaya D, Hoffe S. Using the ALBI Grade as a Prognostic Marker for Radioembolization of Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.1081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
118
|
O'Neil B, O'Reilly S, Kasbari S, Kim R, McDermott R, Moore D, Grogan W, Cohn A, Bekaii-Saab T, Ivanova A, Olowokure O, Fernando N, McCaffrey J, El-Rayes B, Horgan A, Ryan T, Sherrill G, Yacoub G, Goldberg R, Sanoff H. A multi-center, randomized, double-blind phase II trial of FOLFIRI + regorafenib or placebo for patients with metastatic colorectal cancer who failed one prior line of oxaliplatin-containing therapy. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw370.13] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
119
|
Ioannides P, Abuodeh Y, Jin W, Hoffe S, Frakes J, Kim R, Choi J, El-Hadda G, Biebel B, Kis B, Sweeney J, Friedman M, Kothari N, Anaya D, Latifi K. Impact of Sarcopenia Evaluated Using the Total Psoas Area (TPA) in Patient Undergoing Y-90 Radioembolization for Hepatocellular Carcinoma (HCC). Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
120
|
Jin W, Mellon E, Hoffe S, Frakes J, Springett G, Centeno B, Kim R, Mahipal A, Pimiento J, Malafa M, Latifi K. Does Metabolic Tumor Volume Predict Tumor Regression Grade After Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer? Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.1083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
121
|
Choi J, Kim R, Kim W. Transcriptional profiling and biological pathway in larval zebrafish exposed to zinc oxide nanoparticles (nZnO). Toxicol Lett 2016. [DOI: 10.1016/j.toxlet.2016.06.1942] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
122
|
Kang B, Kim R, Lee SB, Kwon SK, Kim YH, Cho K. Side-Chain-Induced Rigid Backbone Organization of Polymer Semiconductors through Semifluoroalkyl Side Chains. J Am Chem Soc 2016; 138:3679-86. [DOI: 10.1021/jacs.5b10445] [Citation(s) in RCA: 202] [Impact Index Per Article: 25.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
123
|
Kim R, Goldenberg S, Duff P, Nguyen P, Gibson K, Shannon K. High uptake of a women-only and sex-work-specific drop in center independently linked to sexual and reproductive health care for sex workers. Contraception 2015. [DOI: 10.1016/j.contraception.2015.06.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
124
|
Kim R, Kwon H, Lee YH, Yook KH, Song J, Song MA, Hong HJ. Risky Behavior Subtypes and Suicide Attempts in Adolescents with Depression. Soa Chongsonyon Chongsin Uihak 2015. [DOI: 10.5765/jkacap.2015.26.3.149] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
125
|
Kim R, Kim K, Kim J, Park J, Choi I. 709 Surveillance of relapse with 18F-flurodeoxyglucose positron emission to-mography/computed tomography in diffuse large B-cell lymphoma after achieving complete remission with rituximab containing regimen. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30379-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|